Medpace Holdings, Inc.
MEDP· Nasdaq
Released Feb 16, 2021, before the open
10-K filed Feb 16, 2021, 47 days after period end · 0001564590-21-006072
derived · Computed from the longer spans the company filed.
| Metric | Q4 2020dderived from reported figures | Q4 2019 | Q4 2018 | Q4 2017 |
|---|---|---|---|---|
| Revenue | $259.68M | $229.89M | $192.12M | $112.68M |
| Net Income | $50.87M | $29.81M | $22.76M | $11.29M |
Medpace Holdings, Inc. · CIK 1668397 · Engraved from SEC EDGAR
| EPS Diluted | — | $0.78 | $0.61 | $0.30 |
|---|
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.